These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17558446)

  • 41. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.
    Hazai E; Joshi P; Skoviak EC; Suryanarayanan A; Schulte MK; Bikadi Z
    Bioorg Med Chem; 2009 Aug; 17(16):5796-805. PubMed ID: 19640719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.
    Ivanov AA; Barak D; Jacobson KA
    J Med Chem; 2009 May; 52(10):3284-92. PubMed ID: 19402631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Site-directed mutagenesis of the serotonin 5-Hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding.
    Muntasir HA; Takahashi J; Rashid M; Ahmed M; Komiyama T; Hossain M; Kawakami J; Nashimoto M; Nagatomo T
    Biol Pharm Bull; 2006 Aug; 29(8):1645-50. PubMed ID: 16880620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
    Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
    Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular modeling studies on the human neuropeptide S receptor and its antagonists.
    Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Vittori S; Volpini R; Cristalli G
    ChemMedChem; 2010 Mar; 5(3):371-83. PubMed ID: 20087922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular modelling of the 5-hydroxytryptamine receptors.
    Wishart G; Bremner DH; Sturrock KR
    Recept Channels; 1999; 6(4):317-35. PubMed ID: 10412724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
    Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
    Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
    Kurczab R; Bojarski AJ
    J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homology modelling of the serotoninergic 5-HT2c receptor.
    Farce A; Dilly S; Yous S; Berthelot P; Chavatte P
    J Enzyme Inhib Med Chem; 2006 Jun; 21(3):285-92. PubMed ID: 16918076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding the regulation mechanisms of PAF receptor by agonists and antagonists: molecular modeling and molecular dynamics simulation studies.
    Gui C; Zhu W; Chen G; Luo X; Liew OW; Puah CM; Chen K; Jiang H
    Proteins; 2007 Apr; 67(1):41-52. PubMed ID: 17243151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aromatic interactions impact ligand binding and function at serotonin 5-HT
    Córdova-Sintjago T; Villa N; Fang L; Booth RG
    Mol Phys; 2014 Jan; 112(3-4):398-407. PubMed ID: 24729635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
    Shim JY; Welsh WJ; Howlett AC
    Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The neural γ
    Ayan M; Essiz S
    J Mol Model; 2018 Jul; 24(8):206. PubMed ID: 30008086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior.
    Anastasio NC; Gilbertson SR; Bubar MJ; Agarkov A; Stutz SJ; Jeng Y; Bremer NM; Smith TD; Fox RG; Swinford SE; Seitz PK; Charendoff MN; Craft JW; Laezza FM; Watson CS; Briggs JM; Cunningham KA
    J Neurosci; 2013 Jan; 33(4):1615-30. PubMed ID: 23345234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.
    Acuña-Castillo C; Villalobos C; Moya PR; Sáez P; Cassels BK; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jun; 136(4):510-9. PubMed ID: 12055129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
    Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
    Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.